Our first clinical trial, MINDSTIM has successfully concluded!

In total, eight volunteers participated. Based on the MRI scans of each participant, a custom-made, 34-channel Miamind® Neurostimulator including a personalized tACS therapy was designed and 3D printed. Thanks to the personalized design and therpay plan a defined electric field was delieverd at selected brain regions. Over multiple, personalized tACS sessions, the participants brain activity was monitored using the integrated EEG functionality of the custom-made Miamind® Neurostimulator.

Currently, the data is beeing analysed. Initial findings suggest promising outcomes, affirming the safety and feasibility of both the Miamind® Neurostimulator and its repetitive, personalized tACS sessions for clinical applications.

Stay tuned for more updates on this significant milestone in our journey towards a non-invasive Alzheimer's disease therapy. A heartfelt thank you to all involved, especially our dedicated volunteer participants.